Botulinum Toxin Enhanced Foker Process for Long Gap Esophageal Atresia
Author / Expert
Shawn Izadi, Donna C. Koo, Hester F. Shieh, Megan Z. Chiu, Farokh R. Demehri, Somala Mohammed, Steven J. Staffa, Jason Smithers, Benjamin Zendejas
Topic overview
The traction-induced esophageal growth (Foker) process for the treatment of long gap esophageal atresia (LGEA) relies on applying progressive tension to the esophagus to induce growth. Due to its anti-fibrotic and muscle-relaxing properties, we hypothesize that Botulinum Toxin A (BTX) can enhance traction-induced esophageal growth.
Comments